Duloxetine HCl
| Tên sản phẩm | Duloxetine HCl |
|---|---|
| Số CAS | 136434-34-9 |
| Công thức phân tử | C18H19NOS·HCl |
| Trọng lượng phân tử | 333.88 g/mol |
| Hình thức | Bột tinh thể màu trắng đến trắng ngà |
| Phương pháp phân tích (HPLC) | 98.0% – 102.0% (on dried basis) |
| Mất mát khi sấy khô | ≤ 0,5% |
| Hàm lượng tro sau khi đốt | ≤ 0,1% |
| Kim loại nặng | ≤ 20 ppm |
| Gói | 25 kg fiber drum with double polyethylene bags |
Cần trợ giúp? Liên hệ với đội ngũ của chúng tôi

Từ đồng nghĩa: (S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride, LY248686, Duloxetine hydrochloride, Cymbalta, Yentreve, Ariclaim, Xeristar
Duloxetine HCl is a dual serotonin and norepinephrine reuptake inhibitor (SNRI) that has become a cornerstone in the treatment of major depressive disorder, generalized anxiety disorder, and neuropathic pain. As a hydrochloride salt, it offers improved aqueous solubility and stability compared to the free base, making it the preferred form for oral solid dosage formulations. The compound was originally developed by Eli Lilly and received FDA approval in 2004 under the brand name Cymbalta.
Chemically, duloxetine HCl is a naphthalenyloxy-substituted thiophene propanamine. Its structure features a chiral center, and the active pharmaceutical ingredient is the (S)-enantiomer, which is significantly more potent than the (R)-enantiomer. The molecule’s lipophilic naphthalene and thiophene rings facilitate blood-brain barrier penetration, while the secondary amine side chain is responsible for its interaction with serotonin and norepinephrine transporters. This dual mechanism distinguishes it from selective serotonin reuptake inhibitors (SSRIs) and contributes to its broader efficacy profile.
From a manufacturing perspective, duloxetine HCl is synthesized through a multi-step process that typically starts from 1-naphthol and 2-acetylthiophene, followed by a resolution step to isolate the desired (S)-enantiomer. The final hydrochloride salt is crystallized to high purity, with particle size distribution carefully controlled to ensure consistent dissolution and bioavailability in finished dosage forms. Our material is produced under cGMP conditions and is supported by a comprehensive regulatory package, including DMF and CEP where applicable.
| Tham số | Thông số kỹ thuật |
|---|---|
| Phương pháp phân tích (HPLC) | 98.0% – 102.0% |
| Xác định | IR and HPLC retention time match reference standard |
| Mất mát khi sấy khô | ≤ 0,5% |
| Hàm lượng tro sau khi đốt | ≤ 0,1% |
| Kim loại nặng | ≤ 20 ppm |
| Giới hạn vi sinh vật | Total aerobic count ≤ 1000 CFU/g; Yeast & mold ≤ 100 CFU/g; E. coli absent |
Room,5-0203, Unit 5, Beiyuanmen Street,Xi'an,Shaanxi,China